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Summary Nuclear polyploidization in the livers of CF-I mice, exposed to dieldrin (0, 1, 5 and lOppm in the
diet), was studied up to the median time of liver tumour development (ranging from 15 to 27 months) in the
respective treatment groups. In untreated controls nuclear polyploidization is characterized by a linear
increase of octaploid nuclei with age. Approximately 4 months before tumour development a reduction in the
tetraploid to diploid ratio is observed. Dieldrin treatment was found to enhance nuclear polyploidization in
the initial phases of treatment, as expressed by a dose-dependent increase in octaploid nuclei. In 'steady-state'
situations all age dependent changes in the level of polyploidization found in controls were also found in
dieldrin treated mice. However, these changes occurred at an increasingly earlier age with higher dieldrin
treatment levels. The decrease in the tetraploid:diploid ratio always takes place a few months before tumour
development. This change in the ploidy level may thus be related to the subsequent liver tumour formation.
The liver tumours themselves appear to originate from a diploid stem line, and were found to increase their
degree of polyploidization during growth, eventually developing aneuploid nuclei. A comparison of nuclear
polyploidization and liver tumour formation in CF-1 mouse liver for the given dietary dieldrin concentrations
showed that liver tumour formation was associated with a constant level of polyploidization. Since
polyploidization is an age-dependent process, these findings suggest that liver tumour formation is imminent
at a constant biological age and that dieldrin may advance the biological age of CF-I mouse liver.
The CF-l mouse strain is characterized by the development
of 'spontaneous' liver tumours when they reach an advanced
age. Continuous treatment with microsomal enzyme
inducers, such as drugs, food additives and pesticides, results
in an induction of liver microsomal enzyme systems, liver
enlargement and an in increase in total liver DNA in the
initial phases of treatment (Wright et al., 1972,1977; Ten-
nekes et al., 1981). Thereafter a 'steady-state' situation is
maintained, in which the aforementioned remain on a pla-
teau level (i.e., no further increases or decreases of the
parameters occur). The induced changes are reversible upon
withdrawal and elimination of the compound and are not
accompanied by evidence of liver damage. Thus, these
changes are likely to be an adaptation of the liver to
increased functional demands. However, exposure to micro-
somal enzyme inducers, such as dieldrin has been shown to
enhance liver tumour formation in these mice (Walker et al.,
1973; Tennekes et al., 1985).
Microsomal enzyme inducers are also known to enhance
nuclear polyploidization in rodent liver (Bohm & Nolte-
meyer, 1981). In a recent study (van Ravenzwaay et al.,
1987) it was reported that nuclear polyploidization in livers
of CF-I mice increased proportionally to the dietary dieldrin
concentration within a few weeks after the initiation of
treatment. In 'steady-state' situations only an age-dependent
increase in nuclear polyploidization was found, which exhi-
bited an equal rate in all treatment groups including
controls. An estimation of the mean level of nuclear polyp-
loidization (employing the linear regression of the data) at
the median time to liver tumour development (=50% inci-
dence) revealed that this level should be the same across all
groups.
The objectives of the present study were to ascertain
whether or not the degree of polyploidization at the median
tumour induction period would be equal across all doses. In
our previous report polyploidization was quantitated by the
proportion of octaploid (8c) and 16c nuclei only. This study
reports the age and dose dependent changes of the other
ploidy classes, diploid (2c) and tetraploid (4c), as well as the
8c and 16c nuclei. Furthermore, the level of nuclear polyploi-
dization in the dieldrin-induced liver tumour was determined.
The greatly reduced glucose-6-phosphatase (E.C. 3.1.3.9)
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enzyme activity in liver nodules was used to ascertain the
presence of preneoplastic foci in sections of normal liver
tissue.
Materials and methods
Chemicals
The fluorochrome DAPI was obtained from Serva,
Heidelberg, FRG. Glucose-6-phosphatase was obtained from
Boehringer, Mannheim, FRG. All other chemicals were
purchased from Sigma Chemical Co., Munich, FRG.
Animals
CF-I mice were kindly provided by Shell Research Ltd.,
Sittingbourne, Kent, UK. The colony was maintained under
SPF conditions at Ivanovas GmbH, Kieslegg, FRG. Wean-
ling female CF-I mice -iere supplied to the German Cancer
Research Centre upon request. The animals were allocated
to groups and acclimatised for 1 week. Dieldrin treatment
commenced at 4-5 weeks of age. The animals were exposed
to 0, 1, 5 or lOppm dieldrin in a C-1000 diet (control and
experimental diets were prepared by Altromin GmbH, Lage,
FRG). Diet and water were given ad libiitum. To determine
polyploidization, between 5 and 11 animals/group were
killed at the indicated exposure time.
The median times to tumour development for the different
treatment groups were derived from previous studies (Walker
et al., 1973; Tennekes et al., 1985): 15.25 months (l0ppm),
21.5 months (5ppm), 27.25 months (1 ppm) and 30.25
months (Oppm).
Isolation of liver nuclei
Animals were weighed and killed by cervical dislocation in
'steady-state' situations (i.e., not before 8 weeks after the
initiation of treatment). Livers were quickly excised, the gall-
bladder was removed and the tissue was weighed. The livers
were chilled in ice-cold 0.25M Sucrose/TKM (0.05M Tris-
HCl, pH7.4, 0.025M KCl and 0.005M MgCl2), for a few
minutes. If tumours were present, livers were then dissected
free from observed nodules and tissues were weighed. For
both tissues one part was used to isolate nuclei, the other
part was used for histochemical analysis.
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Liver nuclei were isolated according to Blobel and Potter
(1966). Nuclear pellets were resuspended in 0.35ml TKM
buffer, and fixed by injection into tubes containing 12ml
absolute ethanol at -20°C.
Flow cytometry
DNA analysis was performed using 4'-6'-diamidino-2-phenyl-
indole dihydrochloride (DAPI) as the quantitative fluoro-
chrome (Stohr et al., 1978). Flow cytometry was carried out
as reported previously (van Ravenzwaay et al., 1987), using
a Cytofluorograph 30 (Ortho Diagnostic Systems). In each
case 40,000 nuclei were measured. The percentages of diploid
and polyploid nuclei were corrected for doublets and higher
aggregates of nuclei according to Beck (1980).
Histochemical analysis
Serial sections of 104um were prepared at -15°C on a
cryostat microtome and used for the enzyme histochemical
procedure. Glucose-6-phosphatase activity was demonstrated
according to the method of Wachstein and Meisel (1956).
Three sections of each liver were projected (magnification
x 45) and digitized using a manual optic picture analyser
(Kontron, Digicon, Munich, FRG) and the proportion of
G-6-Pase deficient preneoplastic foci was subsequently
quantitated.
Results
Nuclear polyploidization in non-nodular liver tissue
In the liver of CF-i mice three distinct ploidy classes could
be found during the entire observation period: diploid,
tetraploid and octaploid nuclei. Nuclei of an even higher
ploidy level, e.g., 16c, were found in aged mice, however
their proportion remained low (<3.5%). Polyploidization in
the livers of untreated control CF-i mice was found to be
determined by two phenomena. Up until the age of 14
months nuclear polyploidization was characterized by a
slight decrease of the proportion of diploid (2c) and tetrap-
loid (4c) nuclei. Between 14 and 25.5 months the proportion
of 4c nuclei decreased at a higher rate. Concomitantly, the
proportion of 2c nuclei did not decrease any further or even
increased somewhat. The percentage of octaploid (8c) nuclei
was found to increase linearly with age during the entire
experimental observation period (Figure 1).
Continuous feeding of dieldrin at dietary concentrations of
1, 5 and 10ppm was found to enhance the proportion of 8c
nuclei linearly with the treatment level in the initial phases of
treatment, as reported previously (9). In these phases the
percentages of 2c and 4c nuclei decreased slightly with
increasing dieldrin dose.
The percentage of 8c nuclei was found to increase propor-
tionally with age, the rate of this process being the same in
all treatment groups including controls, until liver tumour
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Figure 1 Mean percentages and standard deviation of diploid
(2c), tetraploid (4c), and octaploid (8c) liver nuclei in untreated
control CF-I mice. The 8c value includes 1.5% 16c nuclei at 25.5
months.
formation (i.e., death). In untreated controls the experiment
was terminated after 25.5 months (i.e., 4.5 months before the
median time to liver tumour development in this group)
because the number of mice surviving 30 months was not
expected to be high enough to determine polyploidization.
Therefore no data for polyploidization were obtained at the
median time to liver tumour development in untreated
control CF-I mice.
In all treatment groups an age-dependent decrease of the
proportion of 2c and 4c nuclei was found, similar to the one
observed in controls. Also similarly to controls, the loss of 4c
nuclei increased in the later phases of life and continued to
increase until liver tumour development. During these
months the percentage of 2c nuclei was found to increase
(Figures 2-4). The induction of the change in the 4c:2c ratio
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Figure 2 Mean percentages and standard deviation of 2c, 4c
and 8c liver nuclei in CF-I mice treated with 1 ppm dieldrin in
the diet. The 8c value includes 1.2% 16c nuclei at 22 months and
1.3% at 27.25 months.
5 ppm dieldrin
._
a)
60-
50-
40-
30-
20-
10 -
Animal number
10 7 6
I I I I
5 5
I i2C
-14C 8_
2 4 6 8 10 12 14 16 18 20 22 24 26 28
Time (months)
Figure 3 Mean percentages and standard deviation of 2c, 4c
and 8c liver nuclei in CF-I mice treated with 5ppm dieldrin in
the diet. The 8c value includes 0.9% 16c nuclei at 9 months and
2.6% at 21.5 months.
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Figure 4 Mean percentage and standard deviation of 2c, 4c and
8c liver nuclei in CF-i mice treated with 10ppm dieldrin in the
diet. The 8c value includes 1.9% 16c nuclei at 9 months and
3.5% at 15.25 months.
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Table I Nuclear polyploidization at the median time to liver tumour formation
in CF-i mice exposed to a dietary dieldrin concentration of 1, 5 and lOppm
Median liver tumour Percentage
Dieldrin dose induction period
(ppm) (months) 2c 4c 8c
1 (5)' 27.25 51.6+3.8 22.4+2.8 21.0+2.2
5 (5)' 21.5 54.6+3.5 23.6+3.0 21.2+2.0
10 (6)a 15.25 52.5+4.1 23.4+5.5 20.8+ 1.0
aNumber of mice used for determination of polyploidization is indicated in
parentheses.
appeared to be dose-dependently advanced in time by the
dietary dieldrin concentration. In controls the change in the
4c:2c ratio was first observed after 25.5 months, with a
treatment of 1ppm dieldrin after 21.5 months, with Sppm
after 14 months and with lOppm after 9 months (Figures
1-4).
At the median time to liver tumour formation polyploid-
ization was found to be approximately the same in all
treatment groups (Table I).
Extrapolation of the linear regression of the percentage of
8c nuclei against time for untreated controls (experimental
observation until 25.5 months) to the median time of tumour
development in this group (30 months) gives an expected 8c
proportion of 21.8%. This value is in agreement with the
ones obtained for dieldrin-treated CF-I mice (Table I), and
emphasizes that liver tumour formation is associated with a
constant level of polyploidization.
Nuclear polyploidization in liver nodules
Liver nodules, dissected free from the surrounding normal
liver tissue were stained for glucose-6-phosphatase activity.
G-6-Pase negative nodules (Figure 5) were divided into three
groups according to their weight and were subsequently
analysed for polyploidization.
Liver nodules with a weight <300mg contained mainly 2c
nuclei. With increasing weight the proportion of 2c nuclei
decreased and the proportion of 4c nuclei increased. In
nodules weighing >500mg even 8c nuclei were found (Table
II). In liver nodules weighing <500mg no aneuploid nuclei
could be detected. However, the large nodules (>500mg)
contained -7% aneuploid nuclei (Table II). Interestingly, all
of these nodules contained an aneuploidy class of -2.8c.
Some of the nodules were found to have additional aneup-
loidy classes of 1.6c and 5.0.c
Quantitation ofpreneoplastic foci
Slices of non-nodular liver tissue were stained for glucose-6-
phosphate activity to ascertain whether or not microscopic
preneoplastic foci were present. If present, the number of G-
6-Pase negative foci was quantitated. It was found that foci
Figure 5 Glucose-6-phosphatase negative liver nodule and sur-
rounding normal liver tissue from a CF-i mouse treated with
lOppm dieldrin for 14 months.
Table II Nuclear polyploidization (%) in glucose-6-phosphatase
negative liver nodules taken from CF-1 mice treated with 5 and
1Oppm dieldrin in the diet
Tumour weight
<300mg(3)a 300 500mg(4) >500mg(4)
Ploidy class (%) (%) (%)
2c 82.3+3.1 65.1 +9.1 40.3+ 16.5
4c 15.5+4.8 32.3+6.8 40.5+16.4
8c 0.0 0.0 10.8+ 7.2
aneuploidyb 0.0 0.0 7.2+ 5.9
aNumber of nodules used to determine nuclear polyploidization is
indicated in parenthese; baneuploidy classes found were: 1.6c, 2.8c
and 5.0c.
in non-nodular liver tissue could be detected only at the end
of the median tumour induction period (i.e., at the end of
the study). The number of G-6-Pase negative foci found was:
lOppm (15.25 months exposure): 2.9+1.6% (n=4), Sppm
(21.5 months exposure): 1.32+0.31% (n=4), 1 ppm (27.25
months exposure): 2.00+0.82% (n=4), 0ppm (25.5 months
exposure): 0.65 +0.35% (n=4). In all other cases the number
of G-6-Pase deficient foci was negligible.
Discussion
The quantitation of glucose-6-phosphatase negative preneop-
lastic foci in non-nodular liver tissue showed that the volume
occupied by these foci was very low (<2.9% in all cases).
Their presence thus cannot be expected to have a significant
impact of the results of the determination of nuclear polyp-
loidization in non-nodular liver tissue.
The percentage of 8c nuclei in the liver of CF-I mice was
found to be dose-dependently enhanced during the initial
phases of dieldrin treatment. Probably related to the increase
in nuclear polyploidization, a dose-dependent decrease in the
amount of binucleate cells was observed when slices of liver
tissue were examined by light-microscopy for routine patho-
logy. This finding suggests that nuclear polyploidization may
result from nuclear fusion in binucleate cells.
Figure 6 Metastasis of a liver tumour in CF-1 mouse lung.ACCELERATED POLYPLOIDIZATION AND TUMOUR FORMATION 55
In 'steady-state' situations the percentage of 8c nuclei
increases linearly with age. At the median time to liver
tumour development the mean value of 8c nuclei, for all
treatment groups including controls, was 21.3+0.53% These
findings confirm our previous extrapolations (van Raven-
zwaay et al., 1987) which were based on observations until 14
months of treatment. In our earlier report (van Ravenzwaay
et al., 1987) it was proposed that liver tumour formation was
imminent at a constant biological age of mouse liver.
Dieldrin may thus operate as a tumour promotor by advanc-
ing the biological age of the liver in a mouse strain prone to
age-related 'spontaneous' liver tumour formation. The results
of this study further emphasize this concept. As shown in
Figures 1-4, the proces of polyploidization (i.e., the kinetics
of 2c, 4c and 8c nuclei) observed in untreated controls can
also be found in dieldrin treated CF-I mice but at an
increasingly earlier age (i.e. at a higher velocity) with higher
dietary dieldrin concentrations. The time-gaps created by
dieldrin between the biological and chronological age of
CF-I mouse liver for both liver tumour formation (Tennekes
et al., 1985) and nuclear polyploidization turned out to be
virtually the same.
In this context it is interesting to note that dietary
restriction, which presumably decreases the level of func-
tional pressure on hepatocytes, has been reported to result in
an increased life-span, reduced incidences of (liver) tumours
(Conybeare, 1980), and, strikingly, reduced levels of polyp-
loid nuclei (Enesco & Samborsky, 1983). It would thus
appear that the observed quantitative relationship between
the degree of nuclear polyploidization and liver tumour
formation is related to the functional pressure exerted upon
hepatocytes.
An interesting feature in the observed kinetics of nuclear
polyploidization is the decrease in the 4c:2c ratio. The onset
of this decrease occurs approximately 4 months before the
median time to liver tumour development in all treatment
groups including controls. A decrease in the 4c:2c ratio
during carcinogenesis is not an entirely new observation.
Neil et al. (1976) have found that the administration of
aflatoxin B1 resulted in a decrease of 4c nuclei. Styles et al.
(1976) have also reported a decrease in the 4c:2c ratio when
rats were exposed to the liver carcinogen 3'-methyl-4-dimeth-
ylaminoazo-benzene. Moreover, it has been reported that 4c
nuclei bind more than twice the amount of carcinogen than
2c nuclei (Tulp et al., 1980). Thus, it would appear that 4c
nuclei are more sensitive than other ploidy classes.
The fate of the disappearing 4c nuclei is not yet known,
however, some mechanisms can be proposed and their
implications for hepatocarcinogenesis discussed.
1. Tetraploid cells could, assuming that they are more
sensitive to toxicity than other ploidy classes, die when
(cumulative) toxic stress goes beyond their homeostatic
barriers. Since measurements were performed during
'steady-state' situations, i.e., with no gross increase or
decrease of liver weight, the 4c nuclei in necrotic cells
must be replaced by cells containing 2c nuclei (the
kinetics of 8c nuclei are not affected by the change in
the 4c:2c ratio). The reduction of 4c nuclei ranges
between 15%-20% of the total number of liver nuclei.
Since tetraploid nuclei and cells are twice the size of
diploid ones (Schwarze et al., 1986), two diploid cells
have to divide to replace one tetraploid cell. Therefore,
the observed decrease in the 4c:2c ratio should result in
a strong proliferative signal in the diploid population.
By this mode of action the intrinsic neoplastic potential
of CF-I mouse liver may be activated resulting in liver
tumour formation.
2. A decrease in the 4c:2c ratio could also occur if the
percentage of tetraploid cells were reduced by amitotic
nuclear division as observed for polyploid rat liver
nuclei (Glass, 1957) and for rabbit trophoblasts (Zybina
et al., 1975). In such a case several mechanisms could
explain the subsequent tumourigenesis
(a) Spontaneous mutations may be duplicated by
polyploidization resulting in a heterozygous situa-
tion -MMmm-. Nuclear division of such a tetrap-
loid cell would, by means of random segregation of
chromosomes, result in the occurrence of some
diploid -mm- cells, homozygous for the carcinoge-
nesis mutation, a concept which has been advanced
previously (Kinsella & Radman, 1978; Kunz et al.,
1982).
(b) Since males, females and their offspring are all
characterised equally by the development of 'spon-
taneous' liver tumours (Walker et al., 1973; Ten-
nekes et al., 1982) it could be suggested that the
neoplastic factor is present in a homozygous form
in all CF-I mice. Amitotic division may increase the
likelihood that genetic mechanisms, such as translo-
cation, amplification or deletion will activate a
neoplastic factor.
The results of the determination of nuuclear polyploidiza-
tion in liver nodules show an increasing occurrence of
polyploid nuclei with increasing weight (i.e., age) of nodules
(Table II). Medvedev and Medvedeva (1985) have also
reported that nuclei with a high ploidy level were found only
in the larger 'spontaneous' hepatocarcinomas of CBA mice.
In this report it has been shown that in the largest liver
nodules -7% of all nuclei were aneuploid. Aneuploidy is
generally regarded as a situation indicating malignancy. It
has indeed been found that the 'spontaneous' liver tumours
of CF-I mice do become malignant and metastasize, as
shown in Figure 6. The shift from 2c to 4c and 8c nuclei in
liver nodules with increasing weight (Table II) suggests that
the origin of the liver nodules may be found in the diploid
population. This would be in agreement with the proposed
mechanisms for the activation of the intrinsic neoplastic
potential of CF-I mice, which all implicate the diploid
population as the source of CF-I mouse liver tumours.
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